Summit Therapeutics plc Skyrocketed
Tue, Dec 06, 2022 at 07:03 PM
Summit Therapeutics plc (SMMT:NASDAQ) jumped higher at $2.31, a gain of 194.3%. On Tue, Dec 06, 2022, SMMT:NASDAQ hit a New 2-Week High of $2.31. The stock got featured on our News Catalysts scanner on Tue, Dec 06, 2022 at 12:43 PM in the 'AGREEMENT' category. From Tue, Nov 22, 2022, the stock recorded 55.56% Up Days and 60.00% Green Days
About Summit Therapeutics plc (SMMT:NASDAQ)
Summit Therapeutics PLC is a biopharmaceutical company focused on the discovery, development and commercialization of novel medicines for indications for which there are no existing or only inadequate therapies.
Top 10 Gainers:
- Summit Therapeutics plc (SMMT:NASDAQ), 194.27%
- Pacifico Acquisition Corp. (PAFO:NASDAQ), 60.6%
- Eterna Therapeutics Inc Com (New) (ERNA:NASDAQ), 43.87%
- Ra Medical Systems, Inc. (RMED:NYSE), 33.09%
- Vivint Smart Home, Inc. (VVNT:NYSE), 32.37%
- Studio City International Holdings Limited (MSC:NYSE), 30.44%
- Tantech Holdings Ltd (TANH:NASDAQ), 23.37%
- DoubleDown Interactive Co. Ltd. (DDI:NASDAQ), 21.95%
- BurgerFi International Inc (BFI:NASDAQ), 21.07%
- Signet Jewelers Limited (SIG:NYSE), 20.25%